Literature DB >> 21248500

Incidence, predictors, costs, and outcome of renal cell carcinoma after kidney transplantation: USRDS experience.

Frank P Hurst1, Rahul M Jindal, Lindsey J Graham, Edward M Falta, Eric A Elster, George B Stackhouse, Lawrence Y Agodoa, Krista L Lentine, Moro O Salifu, Kevin C Abbott.   

Abstract

INTRODUCTION: We carried out an analysis of the United States Renal Data System to determine the incidence, risk factors, prognosis, and costs associated with the diagnosis of renal cell carcinoma (RCC) after kidney transplantation.
METHODS: This is a retrospective cohort of 40,821 Medicare primary renal transplant recipients transplanted from January 1, 2000, to July 1, 2005, and followed up till December 31, 2005, excluding those with prior RCC or nephrectomy. Kaplan-Meier analysis was performed to determine the time of occurrence of RCC, and Cox regression was used to determine factors associated with RCC.
RESULTS: Three hundred sixty-eight patients were diagnosed with RCC within 3 years after transplant (incidence of 3.16 per 1000 person years). The 3-year incidence of RCC posttransplant was 9.29 per 1000 person years (2.3%) for those with pretransplant cysts and 3.08 per 1000 person years (0.7%) without pretransplant cysts. RCC was diagnosed disproportionately early posttransplant in patients with cysts. Cysts were independently associated with increased risk of RCC, as was male gender, older recipient, donor age, African American recipient, increased time on dialysis and acute rejection within first year posttransplant. RCC was associated with increased risk of mortality with a higher risk with pretransplant cysts. Patients who developed RCC had higher cumulative median costs ($55,456 at 2 years) than those who did not develop RCC ($40,369). There was no "clustering" of RCC in individual states or centers more than would be expected by chance.
CONCLUSION: RCC was diagnosed disproportionately early in patients with pretransplant renal cysts and was associated with a worse prognosis and increased costs.

Entities:  

Mesh:

Year:  2010        PMID: 21248500     DOI: 10.1097/TP.0b013e3181f30479

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  10 in total

1.  Clinical and Economic Consequences of Early Cancer After Kidney Transplantation in Contemporary Practice.

Authors:  Vikas R Dharnidharka; Abhijit S Naik; David Axelrod; Mark A Schnitzler; Huiling Xiao; Daniel C Brennan; Dorry L Segev; Henry Randall; Jiajing Chen; Bertram Kasiske; Krista L Lentine
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

Review 2.  Malignancies after pediatric kidney transplantation: more than PTLD?

Authors:  Martin Mynarek; Kais Hussein; Hans H Kreipe; Britta Maecker-Kolhoff
Journal:  Pediatr Nephrol       Date:  2013-09-24       Impact factor: 3.714

3.  Renal cell cancer after kidney transplantation.

Authors:  Dennis Kleine-Döpke; Matthias Oelke; Anke Schwarz; Ysabell Schwager; Frank Lehner; Jürgen Klempnauer; Harald Schrem
Journal:  Langenbecks Arch Surg       Date:  2018-07-12       Impact factor: 3.445

4.  [Urological follow-up and development of cancer after renal transplantation].

Authors:  M Giessing
Journal:  Urologe A       Date:  2015-10       Impact factor: 0.639

5.  Risk of Renal Cell Carcinoma Among Kidney Transplant Recipients in the United States.

Authors:  S Karami; E L Yanik; L E Moore; R M Pfeiffer; G Copeland; L Gonsalves; B Y Hernandez; C F Lynch; K Pawlish; E A Engels
Journal:  Am J Transplant       Date:  2016-06-23       Impact factor: 9.369

Review 6.  Renal Cell Carcinoma and Kidney Transplantation: A Narrative Review.

Authors:  Dag Olav Dahle; Morten Skauby; Carl Wilhelm Langberg; Knut Brabrand; Nicolai Wessel; Karsten Midtvedt
Journal:  Transplantation       Date:  2022-01-01       Impact factor: 5.385

7.  Malignancies after pediatric solid organ transplantation.

Authors:  Cal Robinson; Rahul Chanchlani; Abhijat Kitchlu
Journal:  Pediatr Nephrol       Date:  2020-10-15       Impact factor: 3.714

8.  Sex differences in the development of malignancies among end-stage renal disease patients: a nationwide population-based follow-up study in Taiwan.

Authors:  Chi-Jung Chung; Chao-Yuan Huang; Hung-Bin Tsai; Chih-Hsin Muo; Mu-Chi Chung; Chao-Hsiang Chang; Chiu-Ching Huang
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240

9.  Clinical characteristics and outcomes in renal transplant recipients with renal cell carcinoma in the native kidney.

Authors:  In O Sun; Yu Mi Ko; Eun Young Kim; Kyung Seon Park; Hong Soon Jung; Sun Hye Ko; Byung Ha Chung; Bum Soon Choi; Cheol Whee Park; Yong Soo Kim; Chul Woo Yang
Journal:  Korean J Intern Med       Date:  2013-05-01       Impact factor: 2.884

10.  Risk of cancer in retransplants compared to primary kidney transplants in the United States.

Authors:  Roberto S Kalil; Charles F Lynch; Eric A Engels
Journal:  Clin Transplant       Date:  2015-09-10       Impact factor: 3.456

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.